Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 70518-4165

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide (NDC 70518-4165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label of olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide 40 mg / 5 mg / 25 mg film-coated tablets by RemedyRepack Inc. The package contains 30 tablets for oral use. The label includes dosing strength, quantity, NDC 70518-4165-00, and manufacturer information with storage instructions.*

FDA Label Image

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)

Chemical structure of olmesartan medoxomil, an active ingredient in the medication olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide. The diagram shows the molecular arrangement and bonds clearly in a black line format on a white background.*

FDA Label Image

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)

Chemical structure diagram showing the molecular composition of olmesartan medoxomil and an additional compound, likely related to amlodipine besylate or hydrochlorothiazide. The image displays molecular bonds and atoms as part of the active ingredients in the drug combination.*

FDA Label Image

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)

Chemical structure diagram of the active ingredient olmesartan medoxomil, showing its molecular framework including sulfonamide and chlorinated aromatic components.*

FDA Label Image

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)

A line chart showing multiple data series plotted over time with distinct markers: circles, triangles, diamonds, and squares. The x-axis appears to represent a timeline, while the y-axis ranges approximately from 55 to 100. A legend under the chart identifies series as Baseline and various combinations of 40 mg (likely olmesartan medoxomil), 10 mg (likely amlodipine besylate), and 25 mg hydrochlorothiazide doses, comparing baseline values to different treatment groups.*

FDA Label Image

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)

A line graph titled 'Mean Ambulatory Systolic Blood Pressure at Endpoint by Treatment and Hour,' plotting mean systolic blood pressure (mmHg) on the Y-axis against hours post dose on the X-axis. The graph compares baseline and various treatment groups, including AML 10/HCTZ25, OM40/AML10, OM40/AML10/HCTZ25, and OM40/HCTZ25, showing their blood pressure changes over a 24-hour period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.